LATEST NEWS   MITI allows all remaining existing CBU electric vehicle stock to be sold in accordance with regulations during the special exemption period | All imports of fully built-up (CBU) electric vehicles will be subject to two main conditions from July 1, 2026 — MITI | Policy on CBU electric vehicles reverts to existing rules after special exemption ends Dec 31, 2025 -- MITI | RTM, Unifi TV official broadcasters of FIFA World Cup 2026 in Malaysia - Fahmi | 'Media Integrity Strengthens Credibility' chosen as theme of HAWANA 2026 - Fahmi | 

Curia Burlington Named Massachusetts Manufacturer Of The Year

KUALA LUMPUR, Oct 22 (Bernama) -- Curia Global Inc (Curia) announced its Burlington, Massachusetts, sterile drug product facility has been named “Manufacturer of the Year” by the Massachusetts Legislative Manufacturing Caucus.

The award was presented at the 10th Annual Manufacturing Awards Ceremony, held on Oct 21 at Gillette Stadium, according to Curia in a statement.

“Our employees work with patients in mind every day. This recognition highlights our commitment to quality and innovation in drug manufacturing,” said Curia Burlington General Manager and Site Head, Mari-Kate Alter.

The site is one of four in Curia’s global sterile fill-finish network, which includes operations in California, New Mexico, and the United Kingdom.

The Massachusetts Manufacturing Caucus, made up of over 70 legislators, praised Curia’s contribution to the state’s economy and health sector.

“Curia exemplifies the innovation and impact of manufacturing in the Commonwealth,” said State Representative, Jeffrey Roy.

The award underscores Curia’s role in advancing pharmaceutical manufacturing while supporting high-skill jobs and patient care across Massachusetts.

Curia is a contract research, development and manufacturing organisation (CDMO) with over 30 years of experience, an integrated network of 20 global sites and 3,200 employees partnering with biopharmaceutical customers to bring life-changing therapies to market.

-- BERNAMA